Research progress of dupilumab in the treatment of chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a persistent airflow obstructive disease caused by airway and/or alveolar abnormalities and has become the third leading cause of death worldwide. Dupilumab, the first fully humanized monoclonal antibody targeting the IL-4 receptor subunit alpha (IL-4R...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2025-06-01
|
| Ráidu: | Allergy Medicine |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2949913525000254 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|